SMi Group announce Clinical Trials in CNS, 23rd & 24th November 2011

SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.
By: SMi Group Ltd
 
July 18, 2011 - PRLog -- This conference will bring together leading industry experts to explore the current and future opportunities within CNS drug development. With over a third of global diseases linked to CNS disorders, the conference addresses a vital area of research.

This year’s conference will cover innovative clinical drug discovery strategies and consider new therapeutic targets. CNS drug development techniques and problems encountered in clinical trials will also be discussed. With problem-solving discussions and case study presentations from key industry players, this event is not to be missed.

Key topics to be addressed:
• Cognition enhancement
• Latest developments in MS, PD and AD clinical development
• Biomarkers and CNS clinical trials  
• Participant recruitment and retention issues in CNS clinical trials
• Schizophrenia and depression: specific considerations.
• Efficacy predictions
• Current challenges in translational CNS research
• Facilitating and establishing industry and academic partnering
• Early phase development trials in CNS

Hear keynote addresses from:
• Georg Terstappen, Director and Department Head, Neuroscience Discover, Abbott
• Sophie Dix, Senior Research Scientist, Neurodegenerative Diseases Drug Hunting Team, Lilly
• Florien von Raison, Head of Global Clinical Development Unit, Parkinson’s Diseases, Merck Serono
• Chas Bountra, Chief Scientist, Structural Genomics Consortium, Univeristy of Oxford
• Hitendra Parmar, European Medical Director for Alzheimer’s Disease, Pfizer
• Simon Ridley, Head of Research, Alzheimer’s Research UK

Visit http://www.smi-online.co.uk/2011cnstrials22.asp to reserve your place. Alternatively, contact Aaron Carbon at Tel: +44 (0) 207 827 6104 or Email: acarbon@smi-online.co.uk.

# # #

About SMi Group
Clinical Trials in CNS is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
For further information, contact:
Aaron Carbon
Tel: +44 (0) 207 827 6104
Email: acarbon@smi-online.co.uk
End
Source:SMi Group Ltd
Email:***@smi-online.co.uk Email Verified
Zip:SE1 0HS
Tags:Pharmaceuticals, Clinical Trials, Cns, Drug Development, Biomarkers, R D, Clinical Development
Industry:Event, Medical, Pharmaceuticals
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share